Department of Radiation Oncology

Guideline development GEC ESTRO (2021) Strnad V, Perez-Calatayud J, Jurgenliemk-Schulz I Conference contribution Evaluation of a markerless SGRT-only workflow for breast cancer patients (2021) Sauer TO, Popp D, Ott OJ, Bert C Conference contribution Salvage laryngectomy after primary radio- and radiochemotherapy : A retrospective study (2021) Sievert M, Goncalves M, Binder B, Müller SK, Rupp R, Koch M, Dürr S, et al. Journal article Cell-in-cell phenomenon: leukocyte engulfment by non-tumorigenic cells and cancer cell lines (2021) Bauer M, Hader M, Hecht M, Büttner-Herold M, Fietkau R, Distel L Journal article Therapies for synchronous malignomas - the importance of interdisciplinary oncology (2021) Müller SK, Haderlein M, Traxdorf M, Semrau S, Agaimy A, Lettmaier S, Gostian AO, et al. Journal article, Editorial Neoadjuvant Immunotherapy of Oral Squamous Cell Carcinoma: Case Report and Assessment of Histological Response (2021) Olmos M, Glajzer J, Büntemeyer TO, Frohwitter G, Ries J, Eckstein M, Hecht M, et al. Journal article 12 x 6 Gy stereotactic radiotherapy for lung tumors. Is there a difference in response between lung metastases and primary bronchial carcinoma? (2021) Lubgan D, Semrau S, Lambrecht U, Gaipl U, Fietkau R Journal article Editorial to radiation in multimodal tumor immune therapies—mechanisms and application (2021) Frey B, Gaipl U Journal article SARS-CoV-2-seronegative subjects target CTL epitopes in the SARS-CoV-2 nucleoprotein cross-reactive to common cold coronaviruses (2021) Schmidt K, Nganou-Makamdop K, Tenbusch M, El Kenz B, Maier C, Lapuente D, Überla K, et al. Conference contribution Longitudinal C-reactive protein (CRP) as an individualized dynamic predictor for metastatic cancer patients treated with immune checkpoint inhibitors: Findings from the prospective ST-ICI cohort. (2021) Zhou JG, Ma H, Gaipl U, Frey B, Hecht M, Fietkau R Conference contribution